Merck, Viatris Settle Diabetes Drug Patent Fight After Appeal
Rival drugmakers Viatris and Merck have settled their yearslong dispute over patents on brand name diabetes treatments Januvia and Janumet shortly after their trip to the Federal Circuit began....To view the full article, register now.
Already a subscriber? Click here to view full article